JPMorgan analyst David Adlington lowered the firm’s price target on Medacta Group to CHF 93 from CHF 100 and keeps a Neutral rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MEDGF:
- Medacta Group price target raised to CHF 112 from CHF 105 at Credit Suisse
- Medacta Group price target lowered to CHF 107 from CHF 109 at Morgan Stanley
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue